<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The protective effects of Kamikihi-To (KMK), a traditional Chinese medicine, against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:mp ids='MP_0002316'>anoxia</z:mp> were investigated with various experimental models in mice and gerbils </plain></SENT>
<SENT sid="1" pm="."><plain>KMK (2.0 g/kg/day, p.o. for 5 days) significantly prolonged the survival time of mice subjected to bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>KMK (0.5 and 2.0 g/kg/day, p.o. for 5 days) also prolonged the survival time of mice injected with <z:chebi fb="0" ids="31882">N-methyl-D-aspartic acid</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>: 80 mg/kg, i.v.) </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, KMK (in a diet containing 8% KMK given orally for 34 days) showed protective effects against delayed neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in CA1 pyramidal cells in the gerbil hippocampus after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>On the other hand, we failed to show any protective effects of KMK (0.5-2.0 g/kg/day, p.o. for 5 days) against normobaric <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:chebi fb="0" ids="33191">KCN</z:chebi>-induced cytotoxic <z:mp ids='MP_0002316'>anoxia</z:mp> in mice </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that KMK may have protective effects against cerebral ischemic disorders, but not against severe hypoxic and anoxic disorders </plain></SENT>
</text></document>